Antitumor Effect on Human Gastric Cancer and Induction of Apoptosis by Vascular Endothelial Growth Factor Neutralizing Antibody

Induction of apoptosis by antiangiogenic therapy has been suggested as a new anticancer strategy. To clarify the mechanism of the antitumor effect achieved by inhibition of vascular endothelial growth factor (VEGF), which is a major mediator of angiogenesis, we used an orthotopic transplantation model of human gastric carcinoma line (MT2) treated with a monoclonal VEGF neutralizing antibody (VEGF Ab). We histologically examined the microvessel density (MVD) and the apoptotic index (AI) in this model. Transplanted tumor growth was significantly inhibited by the VEGF Ab (P= 0.03), and there was a significant decrease in the number of mice with liver metastasis (P= 0.004). The MVD detected by immunohistochemical staining with ER‐MP12 antibody was 33.6 ± 8.0 in the control group and 21.1 ± 5.4 in the treated group, and the difference was significant (P < 0.0001). The AI values of the control and treated groups were 4.73 ± 1.11 and 7.26 ± 1.62, respectively, and this difference is also significant (P < 0.0001). However, the expression of VEGF mRNA in transplanted tumors did not show a significant difference between the control and treated groups. These results suggest that the antitumor effect of the VEGF Ab on human gastric carcinoma is exerted by inducing mild hypoxia followed by apoptosis, which does not influence VEGF mRNA expression in the carcinoma.

[1]  Megumi Baba,et al.  Anti‐tumor and anti‐metastatic effects of human‐vascular‐endothelial‐growth‐factor‐neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice , 1998, International journal of cancer.

[2]  D. Ferrari,et al.  Oxidative stress and hypoxia/reoxygenation trigger CD95 (APO‐1/Fas) ligand expression in microglial cells , 1998, FEBS letters.

[3]  H. Suzuki,et al.  An anti-human VEGF monoclonal antibody, MV833, that exhibits potent anti-tumor activity in vivo. , 1998, Hybridoma.

[4]  H. Ikeda,et al.  Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium , 1998, Gut.

[5]  S. Nakashima,et al.  Ceramide Formation Leads to Caspase-3 Activation during Hypoxic PC12 Cell Death , 1998, The Journal of Biological Chemistry.

[6]  L. Nahar,et al.  Regression of Metastatic Liver Tumors in Rats Treated with Angiogenesis Inhibitor TNP‐470: Occurrence of Apoptosis and Necrosis , 1997, Japanese journal of cancer research : Gann.

[7]  Megumi Baba,et al.  Effect of angiogenesis inhibitor TNP‐470 on the progression of human gastric cancer xenotransplanted into nude mice , 1997, International journal of cancer.

[8]  M. O'reilly,et al.  A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. , 1997, Cancer research.

[9]  D. Luxenberg,et al.  Structural identification of the hematopoietic progenitor antigen ER‐MP12 as the vascular endothelial adhesion molecule PECAM‐1 (CD31) , 1997, European journal of immunology.

[10]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[11]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[12]  O. Vinante,et al.  Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. , 1997, Journal of the National Cancer Institute.

[13]  Seamus J. Martin,et al.  Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis , 1996, Cell.

[14]  L. Nahar,et al.  The angiogenesis inhibitor TNP-470 (AGM-1470) improves long-term survival of rats with liver metastasis. , 1996, The Journal of surgical research.

[15]  J. Folkman,et al.  Angiostatin induces and sustains dormancy of human primary tumors in mice , 1996, Nature Medicine.

[16]  Y. Tsujimoto,et al.  Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. , 1996, Cancer research.

[17]  B. Keyt,et al.  Identification of Vascular Endothelial Growth Factor Determinants for Binding KDR and FLT-1 Receptors , 1996, The Journal of Biological Chemistry.

[18]  T. Sawada,et al.  Prognostic value of vascular endothelial growth factor expression in gastric carcinoma , 1996, Cancer.

[19]  S. Kondo,et al.  Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121. , 1995, Cancer research.

[20]  T. Arai,et al.  Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas , 1995, The Journal of pathology.

[21]  R. Warren,et al.  Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. , 1995, The Journal of clinical investigation.

[22]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[23]  H. Konno,et al.  Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. , 1995, Cancer research.

[24]  D. Fisher Apoptosis in cancer therapy: Crossing the threshold , 1994, Cell.

[25]  C. Winterford,et al.  Apoptosis. Its significance in cancer and cancer Therapy , 1994, Cancer.

[26]  D. Ingber,et al.  Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). , 1994, British Journal of Cancer.

[27]  D. Charnock-Jones,et al.  Expression of mRNA for vascular endothelial growth factor in human placenta. , 1993, Journal of reproduction and fertility.

[28]  D. Housman,et al.  p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.

[29]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[30]  R. Hoffman,et al.  Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. , 1993, Cancer research.

[31]  M. D’Incalci,et al.  Apoptosis Biochemical events and relevance to cancer chemotherapy , 1992, FEBS letters.

[32]  J. Folkman What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[33]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[34]  R. Kumar,et al.  Angiogenic molecules and cancer metastasis. , 1998, In vivo.

[35]  Lars Holmgren,et al.  Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.

[36]  J. Winer,et al.  The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. , 1992, Growth factors.

[37]  S. Sen Biochemical events and relevance to cancer chemotherapy , 1992 .

[38]  J. Kerr,et al.  Patterns of cell death. , 1988, Methods and achievements in experimental pathology.

[39]  J. Folkman,et al.  Angiogenic factors. , 1987, Science.